开发一个过程来测量儿童住院患者药物错误的实际危害:从设计到实施
Virginia Mumford1, Magdalena Z Raban1, Ling Li1
1Australian Institute of Health Innovation, Macquarie University, Sydney, New South Wales, Australia.
一个新的过程系统地评估了儿科护理中药物错误的实际危害. 多学科小组在89个案例中发现了伤害,其中包括8起严重伤害事件,改善了药物安全评估.
科学领域:
- 儿科患者的安全性
- 药物错误分析 药物错误分析
- 改善医疗保健质量 改善医疗保健质量
背景情况:
- 药物错误带来了重大风险,但实际危害的数据很少.
- 现有的危害评估方法缺乏详细描述,这阻碍了可重复性.
- 需要一个强大的过程来评估在儿科环境中药物错误造成的现实危害.
研究的目的:
- 设计和实施一种新的过程,以评估药物错误造成的实际伤害.
- 为了评估这个过程在三级儿科医院的有效性.
- 为儿童住院护理中危害评估提供可重复的方法.
主要方法:
- 对26,369个处方单的回顾性审查和对5,137个药物管理的直接观察.
- 将所有已识别的错误赋予潜在损害严重程度等级 (5分级).
- 多学科小组审查了高潜在伤害案例,以确定实际伤害,因果关系和信心水平.
主要成果:
- 28个多学科小组审查了566起案件 (173起处方,393起处方错误).
- 在89个案例中确定了实际的伤害 (22处方,67处方).
- 发现了8例严重伤害 (1处方,7处方);没有发生严重伤害病例.
结论:
- 开发的危害评估过程提供了一个系统的方法来确定药物错误的实际危害.
- 多学科小组组成对于考虑临床,治疗和上下文因素至关重要.
- 这种方法提高了对药物错误在儿科护理中的实际影响的评估.
更多相关视频
06:05The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
Published on: February 19, 2021
10:42Design to Implementation Study for Development and Patient Validation of Paper-Based Toehold Switch Diagnostics
Published on: June 17, 2022
相关概念视频
Errors occurring during blood pressure monitoring
Several factors...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Guidelines and Strategies for Safe Computer Charting
Maintain Confidentiality and Security:
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...
Methods of Documentation III: PIE
